OncoCyte Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Apr '25 Apr 23, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Market Capitalization	74	32	16	32	148	118	Upgrade
Market Cap Growth	97.40%	97.40%	-48.69%	-78.62%	25.55%	33.33%	Upgrade
Enterprise Value	70	33	11	12	120	116	Upgrade
Last Close Price	2.73	1.89	1.99	5.06	31.76	40.36	Upgrade
PS Ratio	49.20	21.30	13.74	39.74	91.06	132.18	Upgrade
PB Ratio	-7.54	-3.26	0.81	0.96	3.07	4.80	Upgrade
P/TBV Ratio	-	-	-	-	-	17.31	Upgrade
EV/Sales Ratio	49.66	21.64	9.60	15.07	73.75	130.37	Upgrade
Debt / Equity Ratio	-0.30	-0.30	0.11	0.09	0.09	0.26	Upgrade
Debt / EBITDA Ratio	0.01	0.01	0.00	-	-	-	Upgrade
Asset Turnover	0.03	0.03	0.02	0.01	0.02	0.03	Upgrade
Quick Ratio	1.41	1.41	1.38	1.85	2.50	0.89	Upgrade
Current Ratio	1.62	1.62	1.49	2.11	2.77	1.03	Upgrade
Return on Equity (ROE)	-910.86%	-910.86%	-76.26%	-35.52%	-88.37%	-93.07%	Upgrade
Return on Assets (ROA)	-26.42%	-26.42%	-15.91%	-13.88%	-13.82%	-42.66%	Upgrade
Return on Capital (ROIC)	-146.37%	-146.37%	-38.88%	-31.60%	-26.30%	-51.52%	Upgrade
Earnings Yield	-65.84%	-151.40%	-134.52%	-191.48%	-32.03%	-18.62%	Upgrade
FCF Yield	-22.94%	-52.98%	-114.30%	-131.09%	-19.08%	-16.93%	Upgrade
Buyback Yield / Dilution	-70.84%	-70.84%	-38.10%	-24.61%	-35.80%	-27.65%	Upgrade

Updated Nov 12, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.